In a Nov. 1 earnings call, Pfizer CEO Albert Bourla said “people wouldn’t see the difference” with the tentative commercial price for its COVID-19 vaccine, which hovers between $110 and $130 per dose, because the vaccine-maker plans for no copays.
Read the full post on Becker's Hospital Review - Healthcare News
